A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether CCX282-B is effective in treating patients with moderate to severe Crohn's Disease.

Phase 2

ChemoCentryx